Agios Pharmaceuticals: 4Q Earnings Snapshot

February 14, 2019

CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $91.8 million in its fourth quarter.

The Cambridge, Massachusetts-based company said it had a loss of $1.58 per share.

The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.65 per share.

The biopharmaceutical company posted revenue of $30 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $21 million.

For the year, the company reported that its loss widened to $346 million, or $6.03 per share. Revenue was reported as $94.4 million.

Agios Pharmaceuticals shares have increased 17 percent since the beginning of the year. The stock has declined 29 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGIO at https://www.zacks.com/ap/AGIO